Gibson Dunn Advises Atossa Therapeutics on Establishing At-the-Market Facility for Sale of up to $50 Million of Common Stock
Atossa Therapeutics, Inc. was represented by Gibson Dunn in the establishment of an at-the-market facility for the sale of up to $50 million worth of its common stock.